Condition
Renal Transplant Infection
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 2 (1)
Trial Status
Completed3
Unknown2
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05756036Completed
Torque Teno Virus: A Biomarker of Immunosuppression
NCT03762473Phase 2CompletedPrimary
Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection
NCT05926076Unknown
COVID-19 Infection
NCT05073822Phase 1Withdrawn
NOMINATE/ Minimisation of Immunosuppression in Kidney Transplantation
NCT03147183CompletedPrimary
Kinetic Study of CD8+ CMV-specific Cellular Immunity in Renal Transplant Patients After Receiving Thymoglobulin
NCT03310255Unknown
Helicobacter Pylori Infection in Renal Transplant Patients
Showing all 6 trials